You are here
Overview of permitted indications and transition arrangements
The transition period for permitted indications ended 5 March 2021 and the information provided on transitioning to permitted indications in Module 1 is no longer relevant. However, the module still provides useful information in relation to selecting permitted indications for your listed medicine.
This online training resource provides an overview of permitted indications and the transition arrangements for medicines listed before 6 March 2018.
The module also provides links to resources that may assist sponsors in meeting the requirements for listed medicines.
This module takes approximately 10 minutes to complete.